SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-006391
Filing Date
2013-11-14
Accepted
2013-11-14 16:29:01
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tbuff_10q.htm 10-Q 704138
2 CERTIFICATION tbuff_ex311.htm EX-31.1 12854
3 CERTIFICATION tbuff_ex312.htm EX-31.2 12570
4 CERTIFICATION PURSUANT tbuff_ex321.htm EX-32.1 7161
5 CERTIFICATION PURSUANT tbuff_ex322.htm EX-32.2 7382
  Complete submission text file 0001354488-13-006391.txt   4096090

Data Files

Seq Description Document Type Size
6 tbuff-20130930.xml EX-101.INS 578633
7 tbuff-20130930.xsd EX-101.SCH 37108
8 tbuff-20130930_cal.xml EX-101.CAL 51120
9 tbuff-20130930_def.xml EX-101.DEF 65563
10 tbuff-20130930_lab.xml EX-101.LAB 224288
11 tbuff-20130930_pre.xml EX-101.PRE 166124
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 131220594
SIC: 2834 Pharmaceutical Preparations